Integrating palliative care early in the treatment of patients with advanced lung cancer not only improved their mood and quality of life, it also extended their lives. In the August 19 New England Journal of Medicine, Massachusetts General Hospital (MGH) investigators report that patients with metastatic non-small-cell lung cancer (NSCLC) who received early palliative care along with standard treatment lived more than two months longer than patients receiving standard care only.

Lung cancer patients receiving palliative care had improved quality of life, extended survival

Mass General study documents impact of adding palliative services to standard cancer care



Watch a video of one patient's story.

The press release:

To read the press release.

Original Article: To read the original New England Journal of Medicine article
Editorial: To read the New England Journal of Medicine editorial
The study researchers:

Vicki Jackson, MD Vicki Jackson, MD
Acting Chief
Palliative Care Service
Jennifer Temel, MD Jennifer Temel, MD
Mass General
Cancer Center

About Palliative Care at Mass General: Palliative care is a medical specialty that helps patients and their families live as fully as possible when faced with a life-threatening illness. Unlike hospice care, which focuses on end-of-life care, palliative services are provided during any phase of an illness, including active treatments such as chemotherapy.

For information about palliative care treatment at Mass General.
About Lung Cancer at Mass General: Lung cancer care at Mass General combines clinical expertise, cutting-edge research, advanced medical technologies and active clinical trials to offer every patient the most appropriate therapies to treat their disease. We are dedicated to ensuring that patients fully understand their diagnosis and treatment options.

For information about the lung cancer treatment program at Mass General.

Media coverage: (some links may no longer be active)